BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 4302535)

  • 1. Antigenic characteristics of lymphomas induced by radiation leukemia virus (RadLV) in mice and rats.
    Ferrer JF; Kaplan HS
    Cancer Res; 1968 Dec; 28(12):2522-8. PubMed ID: 4302535
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunologic characteristics in relation to high and low leukemogenic activity of radiation leukemia virus variants. II. Analysis of the immune response.
    Haran-Ghera N; Rubio N
    J Immunol; 1977 Feb; 118(2):607-11. PubMed ID: 839072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant loss of specific cell-surface antigen and demonstrable type-C virus particles in lymphomas induced by radiation leukemia virus in rats.
    Ferrer JF; Gibbs FA
    J Natl Cancer Inst; 1969 Dec; 43(6):1317-30. PubMed ID: 5396220
    [No Abstract]   [Full Text] [Related]  

  • 4. Protection against radiation leukemogenesis by repeated injections of immune and nonimmune foreign sera.
    Ferrer JF; Lieberman M; Kaplan HS
    Cancer Res; 1973 Jun; 33(6):1339-43. PubMed ID: 4352370
    [No Abstract]   [Full Text] [Related]  

  • 5. Protective effect of immune sera against transplantable Moloney virus-induced sarcoma and lymphoma.
    Pearson GR; Redmon LW; Bass LR
    Cancer Res; 1973 Jan; 33(1):171-8. PubMed ID: 4734119
    [No Abstract]   [Full Text] [Related]  

  • 6. Antigenic characterization of heterozygous mouse lymphomas after immunoselection in vivo.
    Bjaring B; Klein G
    J Natl Cancer Inst; 1968 Dec; 41(6):1411-29. PubMed ID: 4882575
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the relations between virus release and cellular immunosensitivity in Moloney lymphomas.
    Fenyƶ EM; Biberfeld P; Klein E
    J Natl Cancer Inst; 1969 May; 42(5):837-55. PubMed ID: 5785011
    [No Abstract]   [Full Text] [Related]  

  • 8. In vivo antigenic modification of tumor cells. III. Metastatic thymic lymphoma specifically infected by thymotropic retrovirus.
    Iglehart JD; Weinhold KJ; Huper G; Thiel K; Bolognesi DP
    J Natl Cancer Inst; 1981 Jul; 67(1):123-30. PubMed ID: 6265678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic modulation as a mechanism for tumor escape from immune destruction: identification of modulation-positive and modulation-negative mouse lymphomas with xenoantisera to murine leukemia virus gp70.
    Stackpole CW; Cremona P; Leonard C; Stremmel P
    J Immunol; 1980 Oct; 125(4):1715-23. PubMed ID: 6251136
    [No Abstract]   [Full Text] [Related]  

  • 10. Presence of antibody against mouse fetal antigen in the sera from C57BL-6 mice immunized with Rauscher leukemia.
    Ishimoto A; Ito Y
    Cancer Res; 1972 Nov; 32(11):2332-7. PubMed ID: 4343227
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunity and suppression in radiation- and radiation leukemia virus (RadLV)-induced leukemogenesis.
    Yefenof E; Ben-David Y
    Leuk Res; 1986; 10(7):797-801. PubMed ID: 2942733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic comparison of bovine type C virus with murine and feline leukemia viruses.
    Ferrer JF
    Cancer Res; 1972 Sep; 32(9):1871-7. PubMed ID: 4345040
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies of inhibition of tumour cell DNA synthesis by immune cells in Gross virus induced leukemia.
    Finklestein JZ; Byfield J; Tittle K; Imagawa DT
    Rev Eur Etud Clin Biol; 1972 Mar; 17(3):287-92. PubMed ID: 5053619
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of immune factors on the motility of lymphoma cells.
    Cochran AJ; Klein E; Keissling R
    J Natl Cancer Inst; 1972 Jun; 48(6):1657-61. PubMed ID: 4560294
    [No Abstract]   [Full Text] [Related]  

  • 15. Cross-resistance to the transplantation of syngeneic Friend, Moloney, and Rauscher virus-induced tumors.
    Glynn JP; McCoy JL; Fefer A
    Cancer Res; 1968 Mar; 28(3):434-9. PubMed ID: 4867923
    [No Abstract]   [Full Text] [Related]  

  • 16. Serological studies of tumor antigens in chemical- and virus-induced thymic lymphomas.
    Doell RG; Mathieson BJ
    Cancer Res; 1971 Sep; 31(9):1285-9. PubMed ID: 4329884
    [No Abstract]   [Full Text] [Related]  

  • 17. Requirement for direct cellular contact for immunosuppression by a murine virus-induced lymphoma (FBL-3).
    Cimprich RS; Specter S; Friedman H
    J Immunol; 1978 May; 120(5):1473-9. PubMed ID: 659857
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunologic and virologic properties of chemically and gamma-irradiation-induced thymic lymphomas in mice.
    Chan PL; Sinclair NR
    J Natl Cancer Inst; 1972 Jun; 48(6):1629-40. PubMed ID: 5066471
    [No Abstract]   [Full Text] [Related]  

  • 19. A complement-fixation test for detection of viral antigens and infective virus of feline leukemia and sarcoma.
    Sarma PS; Gilden RV; Huebner RJ
    J Am Vet Med Assoc; 1971 Mar; 158(6):Suppl 2:1055+. PubMed ID: 5280565
    [No Abstract]   [Full Text] [Related]  

  • 20. Synergistic cooperation between isoantiserum and immune lymphoid cells: in vitro studies with a syngeneic rat lymphoma.
    Ortiz de Landazuri M; Kedar E; Fahey JL
    J Immunol; 1974 Jun; 112(6):2102-10. PubMed ID: 4825787
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.